RevealAI-Lung
RevealDx
Product specifications |
Information source:
Vendor
Last updated: Sept. 27, 2022 |
General | |
---|---|
Product name | RevealAI-Lung |
Company | RevealDx |
Subspeciality | Chest |
Modality | CT |
Disease targeted | Lung cancer |
Key-features | Nodule malignancy similarity score |
Suggested use | During: interactive decision support (shows abnormalities/results only on demand) |
Data characteristics | |
Population | Incidental nodules and those found during screening |
Input | CT, 3D, contrast, non-contrast |
Input format | DICOM |
Output | Malignancy Similarity Index (mSI) |
Output format | To be determined |
Technology | |
Integration | Integration in standard reading environment (PACS) |
Deployment | Locally on dedicated hardware, Cloud-based |
Trigger for analysis | On demand, triggered by a user through e.g. a button click, image upload, etc. |
Processing time | < 3 sec |
Certification | |
CE
|
Certified,
Class IIa
, MDD
|
FDA
|
No or not yet |
Market presence | |
On market since | 05-2021 |
Distribution channels | contextflow, Amplify SDK |
Countries present (clinical, non-research use) | |
Paying clinical customers (institutes) | |
Research/test users (institutes) | 2 |
Pricing | |
Pricing model | Pay-per-use, Subscription |
Based on | Number of analyses |
Evidence | |
Peer reviewed papers on performance |
|
Non-peer reviewed papers on performance | |
Other relevant papers |